Sumitomo Life Insurance’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $638K | Buy |
826
+19
| +2% | +$14.5K | 0.02% | 240 |
|
|
2025
Q4 | $623K | Buy |
807
+9
| +1% | +$6.11K | 0.02% | 239 |
|
|
2025
Q3 | $449K | Sell |
798
-26
| -3% | -$14.7K | 0.01% | 247 |
|
|
2025
Q2 | $433K | Sell |
824
-1,496
| -64% | -$835K | 0.03% | 244 |
|
|
2025
Q1 | $1.47M | Sell |
2,320
-792
| -25% | -$545K | 0.05% | 145 |
|
|
2024
Q4 | $2.22M | Sell |
3,112
-62
| -2% | -$52K | 0.04% | 111 |
|
|
2024
Q3 | $3.34M | Buy |
3,174
+1,427
| +82% | +$1.59M | 0.07% | 79 |
|
|
2024
Q2 | $1.84M | Sell |
1,747
-225
| -11% | -$218K | 0.04% | 120 |
|
|
2024
Q1 | $1.9M | Sell |
1,972
-79
| -4% | -$75.1K | 0.05% | 130 |
|
|
2023
Q4 | $1.8M | Buy |
2,051
+626
| +44% | +$516K | 0.06% | 120 |
|
|
2023
Q3 | $1.17M | Sell |
1,425
-824
| -37% | -$648K | 0.03% | 154 |
|
|
2023
Q2 | $1.62M | Sell |
2,249
-193
| -8% | -$149K | 0.07% | 119 |
|
|
2023
Q1 | $2.01M | Sell |
2,442
-18
| -0.7% | -$13.6K | 0.17% | 93 |
|
|
2022
Q4 | $1.77M | Sell |
2,460
-36
| -1% | -$26.6K | 0.13% | 105 |
|
|
2022
Q3 | $1.72M | Sell |
2,496
-286
| -10% | -$180K | 0.07% | 96 |
|
|
2022
Q2 | $1.65M | Buy |
2,782
+21
| +0.8% | +$13.7K | 0.05% | 123 |
|
|
2022
Q1 | $1.93M | Sell |
2,761
-40
| -1% | -$25.3K | 0.05% | 125 |
|
|
2021
Q4 | $1.77M | Sell |
2,801
-108
| -4% | -$66.4K | 0.04% | 143 |
|
|
2021
Q3 | $1.76M | Sell |
2,909
-122
| -4% | -$75.7K | 0.05% | 138 |
|
|
2021
Q2 | $1.69M | Sell |
3,031
-488
| -14% | -$247K | 0.05% | 148 |
|
|
2021
Q1 | $1.67M | Sell |
3,519
-171
| -5% | -$83.3K | 0.07% | 160 |
|
|
2020
Q4 | $1.78M | Sell |
3,690
-359
| -9% | -$194K | 0.08% | 140 |
|
|
2020
Q3 | $2.27M | Sell |
4,049
-212
| -5% | -$129K | 0.11% | 102 |
|
|
2020
Q2 | $2.66M | Sell |
4,261
-396
| -9% | -$225K | 0.14% | 82 |
|
|
2020
Q1 | $2.27M | Buy |
4,657
+63
| +1% | +$26K | 0.16% | 89 |
|
|
2019
Q4 | $1.73M | Buy |
4,594
+256
| +6% | +$86.1K | 0.2% | 152 |
|
|
2019
Q3 | $1.2M | Sell |
4,338
-509
| -11% | -$151K | 0.16% | 196 |
|
|
2019
Q2 | $1.52M | Buy |
4,847
+172
| +4% | +$57.3K | 0.18% | 168 |
|
|
2019
Q1 | $1.92M | Sell |
4,675
-505
| -10% | -$208K | 0.26% | 120 |
|
|
2018
Q4 | $1.94M | Buy |
5,180
+126
| +2% | +$46.1K | 0.27% | 121 |
|
|
2018
Q3 | $2.04M | Sell |
5,054
-100
| -2% | -$38.1K | 0.25% | 128 |
|
|
2018
Q2 | $1.78M | Buy |
5,154
+221
| +4% | +$69.1K | 0.22% | 151 |
|
|
2018
Q1 | $1.7M | Sell |
4,933
-217
| -4% | -$75.5K | 0.22% | 152 |
|
|
2017
Q4 | $1.94M | Sell |
5,150
-252
| -5% | -$102K | 0.24% | 137 |
|
|
2017
Q3 | $2.42M | Sell |
5,402
-698
| -11% | -$332K | 0.31% | 109 |
|
|
2017
Q2 | $3M | Buy |
6,100
+1,822
| +43% | +$797K | 0.39% | 78 |
|
|
2017
Q1 | $1.66M | Sell |
4,278
-265
| -6% | -$98.2K | 0.23% | 148 |
|
|
2016
Q4 | $1.67M | Buy |
4,543
+101
| +2% | +$38.4K | 0.24% | 141 |
|
|
2016
Q3 | $1.79M | Buy |
4,442
+1,053
| +31% | +$422K | 0.27% | 124 |
|
|
2016
Q2 | $1.18M | Sell |
3,389
-116
| -3% | -$44.7K | 0.16% | 209 |
|
|
2016
Q1 | $1.26M | Buy |
3,505
+451
| +15% | +$186K | 0.16% | 199 |
|
|
2015
Q4 | $1.66M | Sell |
3,054
-73
| -2% | -$39.6K | 0.21% | 159 |
|
|
2015
Q3 | $1.45M | Sell |
3,127
-48
| -2% | -$25.8K | 0.19% | 180 |
|
|
2015
Q2 | $1.62M | Sell |
3,175
-429
| -12% | -$209K | 0.2% | 182 |
|
|
2015
Q1 | $1.63M | Sell |
3,604
-381
| -10% | -$161K | 0.18% | 197 |
|
|
2014
Q4 | $1.64M | Sell |
3,985
-223
| -5% | -$87.7K | 0.16% | 221 |
|
|
2014
Q3 | $1.52M | Sell |
4,208
-110
| -3% | -$36.9K | 0.15% | 238 |
|
|
2014
Q2 | $1.22M | Sell |
4,318
-1,629
| -27% | -$483K | 0.12% | 251 |
|
|
2014
Q1 | $1.79M | Sell |
5,947
-495
| -8% | -$153K | 0.17% | 208 |
|
|
2013
Q4 | $1.77M | Buy |
+6,442
| New | +$1.85M | 0.16% | 210 |
|
Other funds holding REGN
VCM
N
Sumitomo Life Insurance's REGN Position: Q1 2026 in Review
Sumitomo Life Insurance increased its Regeneron Pharmaceuticals (REGN) stake by 2.4% in Q1 2026, buying an estimated $14.5K and bringing the position to 826 shares worth $638K. The position accounts for 0.02% of the portfolio, ranked #240.
Sumitomo Life Insurance first reported a position in REGN in Q4 2013 and has held it in 50 quarters since. The position peaked at $3.34M in Q3 2024. 1,393 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Sumitomo Life Insurance held 826 shares of Regeneron Pharmaceuticals worth $638K as of Q1 2026.
- Sumitomo Life Insurance bought 19 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $14.5K.
- Regeneron Pharmaceuticals made up 0.02% of Sumitomo Life Insurance's portfolio in Q1 2026, its #240 holding.
- Sumitomo Life Insurance first reported a position in Regeneron Pharmaceuticals in Q4 2013 and has held it in 50 quarters since.
- Sumitomo Life Insurance's Regeneron Pharmaceuticals position peaked at $3.34M in Q3 2024.
- 1,393 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Sumitomo Life Insurance's 13F filing for Q1 2026, filed 12 May 2026.